Nuclear Magnetic Resonance-Based Metabolomics to Predict Early and Late Adverse Outcomes in Ischemic Stroke Treated with Intravenous Thrombolysis.
Licari C, Tenori L, Di Cesare F, Luchinat C, Giusti B, Kura A, De Cario R, Inzitari D, Piccardi B, Nesi M, Sarti C, Arba F, Palumbo V, Nencini P, Marcucci R, Gori AM, Sticchi E.
Licari C, et al. Among authors: kura a.
J Proteome Res. 2023 Jan 6;22(1):16-25. doi: 10.1021/acs.jproteome.2c00333. Epub 2022 Dec 5.
J Proteome Res. 2023.
PMID: 36469426
Free PMC article.